Prescription rates of protective co‐therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines

Abstract

Less than 50% of NSAID users with GI risk factors are given protective co-therapy--even if prescribers are given reminders and cost is not an issue. Direct communication requiring written response significantly increased adherence to guidelines, but achieving higher levels of adherence will require additional strategies.